Evidence map›Paper›PMID 39737567›Full record

ArticleBriefings in bioinformatics2024

STNGS: a deep scaffold learning-driven generation and screening framework for discovering potential novel psychoactive substances.

Dongping Liu, Dinghao Liu, Kewei Sheng, Zhenyong Cheng, Zixuan Liu, Yanling Qiao, Shangxuan Cai, Yulong Li, Jubo Wang, Hongyang Chen and 4 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Applications of artificial intelligence in drug discovery for neurological diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Dongping LiuSchool of Science, China Pharmaceutical University, Nanjing 211198, China.
Dinghao LiuSchool of Science, China Pharmaceutical University, Nanjing 211198, China.
Kewei ShengSchool of Science, China Pharmaceutical University, Nanjing 211198, China.
Zhenyong ChengSchool of Science, China Pharmaceutical University, Nanjing 211198, China.
Zixuan LiuSchool of Science, China Pharmaceutical University, Nanjing 211198, China.
Yanling QiaoKey Laboratory of Drug Monitoring and Control, Drug Intelligence and Forensic Center, Ministry of Public Security, Beijing 100193, China.
Shangxuan CaiState Key Laboratory of Membrane Biology, Peking University School of Life Sciences, Beijing 100871, China.
Yulong LiState Key Laboratory of Membrane Biology, Peking University School of Life Sciences, Beijing 100871, China.
Jubo WangSchool of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Hongyang ChenZhejiang Lab, Hangzhou 311500, China.
Chi HuSchool of Engineering, China Pharmaceutical University, Nanjing 211198, China.
Peng XuKey Laboratory of Drug Monitoring and Control, Drug Intelligence and Forensic Center, Ministry of Public Security, Beijing 100193, China.
Bin DiOffice of China National Narcotics Control Commission, China Pharmaceutical University Joint Laboratory on Key Technologies of Narcotics Control, Beijing 100193, China.
Jun LiaoSchool of Science, China Pharmaceutical University, Nanjing 211198, China.ORCID 0000-0003-0617-5840

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The supervision of novel psychoactive substances (NPSs) is a global problem, and the regulation of NPSs was heavily relied on identifying structural matches in established NPSs databases. However, violators could circumvent legal oversight by altering the side chain structure of recognized NPSs and the existing methods cannot overcome the inaccuracy and lag of supervision. In this study, we propose a scaffold and transformer-based NPS generation and Screening (STNGS) framework to systematically identify and evaluate potential NPSs. A scaffold-based generative model and a rank function with four parts are contained by our framework. Our generative model shows excellent performance in the design and optimization of general molecules and NPS-like molecules by chemical space analysis and property distribution analysis. The rank function includes synthetic accessibility score and frequency score, as well as confidence score and affinity score evaluated by a neural network, which enables the precise positioning of potential NPSs. Applied STNGS framework with molecular docking and a G protein-coupled receptor (GPCR) activation-based sensor (GRAB), we successfully identify three novel synthetic cannabinoids with activity. STNGS constrains the chemical space to generate NPS-like molecules database with diversity and novelty, which assists in the ex-ante regulation of NPSs.

Indexed as

Molecular Docking SimulationPsychotropic DrugsCannabinoidsDeep LearningDrug DiscoveryHumansNeural Networks, ComputerReceptors, G-Protein-CoupledCannabinoidsPsychotropic DrugsReceptors, G-Protein-Coupleddeep scaffold learningensemble learninggenerative frameworknovel psychoactive substancesynthetic cannabinoids

Identifiers

PMID39737567
PMCPMC11684896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.